109 related articles for article (PubMed ID: 38863630)
1. Clinicopathological characteristics and fertility preserving treatment of atypical polypoid adenomyoma.
Wang Q; Shan W; Yang B; Xue Y; Lou Y; Chen X
Front Oncol; 2024; 14():1386931. PubMed ID: 38863630
[TBL] [Abstract][Full Text] [Related]
2. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
Yang B; Xu Y; Zhu Q; Xie L; Shan W; Ning C; Xie B; Shi Y; Luo X; Zhang H; Chen X
Gynecol Oncol; 2019 Apr; 153(1):55-62. PubMed ID: 30674421
[TBL] [Abstract][Full Text] [Related]
3. PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
[TBL] [Abstract][Full Text] [Related]
4. [Atypical polypoid adenomyoma of the uterus: a clinicopathological review of 27 cases].
Bai TJ; Bao DM; Li Y; Wang Y; Cui H; Zhu HL
Zhonghua Fu Chan Ke Za Zhi; 2017 Apr; 52(4):244-248. PubMed ID: 28441840
[No Abstract] [Full Text] [Related]
5. [The long-term efficacy of metformin in megestrol acetate-based fertility-sparing treatment for patients with endometrial atypical hyperplasia and endometrioid endometrial cancer].
Dong YT; Guan J; Yang BY; Yierfulati G; Xue Y; Chen XJ
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):729-735. PubMed ID: 38462352
[No Abstract] [Full Text] [Related]
6. Management of women with atypical polypoid adenomyoma of the uterus: A quantitative systematic review.
Raffone A; Travaglino A; Saccone G; Alviggi C; Mascolo M; De Placido G; Insabato L; Mollo A; Zullo F
Acta Obstet Gynecol Scand; 2019 Jul; 98(7):842-855. PubMed ID: 30714089
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of 44 cases of atypical polypoid adenomyoma of the uterus.
Wang X; Guo Y
BMC Womens Health; 2022 Mar; 22(1):60. PubMed ID: 35246106
[TBL] [Abstract][Full Text] [Related]
8. Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia.
Wu P; Shan W; Xue Y; Wang L; Liu S; Chen X; Luo X
Front Endocrinol (Lausanne); 2023; 14():1286724. PubMed ID: 38250737
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.
Giampaolino P; Di Spiezio Sardo A; Mollo A; Raffone A; Travaglino A; Boccellino A; Zizolfi B; Insabato L; Zullo F; De Placido G; Bifulco G
J Minim Invasive Gynecol; 2019; 26(4):648-656. PubMed ID: 30017893
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy and pregnancy outcomes of fertility-preserving re-treatment after recurrence of the patient with atypical endometrial hyperplasia and early stage endometrial carcinoma].
He YJ; Wang YQ; Tang HR; He M; Rao Y; Zhou R; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2020 Jan; 55(1):21-28. PubMed ID: 32074769
[No Abstract] [Full Text] [Related]
11. Hysteroscopic Transcervical Resection for Atypical Polypoid Adenomyoma of the Uterus: A Valid, Fertility-Preserving Option.
Chiyoda T; Lin BL; Saotome K; Kiyokawa S; Nakada S
J Minim Invasive Gynecol; 2018 Jan; 25(1):163-169.e1. PubMed ID: 29038039
[TBL] [Abstract][Full Text] [Related]
12. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients.
Yang B; Xie L; Zhang H; Zhu Q; Du Y; Luo X; Chen X
J Gynecol Oncol; 2018 May; 29(3):e35. PubMed ID: 29533020
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate.
Nomura H; Sugiyama Y; Tanigawa T; Matoda M; Kanao H; Kondo E; Takeshima N
Arch Gynecol Obstet; 2016 Jan; 293(1):177-181. PubMed ID: 26209972
[TBL] [Abstract][Full Text] [Related]
15. Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma.
Jing CY; Li SN; Shan BE; Zhang W; Tian WJ; Ren YL; Wang HY
Clin Med Insights Oncol; 2022; 16():11795549221110522. PubMed ID: 35875417
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients.
Wu P; Lv Q; Guan J; Shan W; Chen X; Zhu Q; Luo X
Arch Gynecol Obstet; 2022 Oct; 306(4):1135-1146. PubMed ID: 35246715
[TBL] [Abstract][Full Text] [Related]
17. Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome.
Wang L; Luo X; Wang Q; Lv Q; Wu P; Liu W; Chen X
J Gynecol Oncol; 2021 Sep; 32(5):e70. PubMed ID: 34132069
[TBL] [Abstract][Full Text] [Related]
18. [Fertility-preserving treatment outcomes in endometrial cancer and atypical hyperplasia patients with different molecular profiles].
Shao WY; Dong YT; Lyu QY; Liao JB; Xue Y; Chen XJ
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):742-754. PubMed ID: 37849255
[No Abstract] [Full Text] [Related]
19. Oncologic outcomes of conservative treatment of atypical polypoid adenomyoma of the uterus: A two-center experience.
Casadio P; Raffone A; Travaglino A; Raimondo D; Zizolfi B; Armano G; Buonaiuto R; Insabato L; Mollo A; Seracchioli R; Di Spiezio Sardo A
Int J Gynaecol Obstet; 2022 Oct; 159(1):79-85. PubMed ID: 34921691
[TBL] [Abstract][Full Text] [Related]
20. Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia.
Zhang X; Zhao X; Wang C; Lu S; Wang Y; He Y; Wang J; Shen D
Oncol Lett; 2023 Feb; 25(2):52. PubMed ID: 36644134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]